Instalimb Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6M
- Investors
-
14
Instalimb General Information
Description
Developer of a three-dimensional printing and machine learning technology designed to create low-cost prosthetics and orthotics for amputees. The company's technology produces prosthetic braces using three-dimensional printers and modeling software with shape recommendation functions based on an algorithm that reduces the cost to about one-tenth and the delivery time to be shortened, enabling patients to get prosthetics made out of advanced technology.
Contact Information
Website
www.instalimb.comCorporate Office
- Room 06, Center of Garage
- 1-16-3 Yokokawa, Sumida ward
- Tokyo, Chiyoda 130-0003
- Japan
Corporate Office
- Room 06, Center of Garage
- 1-16-3 Yokokawa, Sumida ward
- Tokyo, Chiyoda 130-0003
- Japan
Instalimb Timeline
Instalimb Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Later Stage VC (Series B) | 06-Mar-2024 | $6M | Completed | Generating Revenue | ||
5. Accelerator/Incubator | 06-Oct-2023 | Completed | Generating Revenue | |||
4. Later Stage VC (Series A) | 13-Jul-2022 | Completed | Generating Revenue | |||
3. Seed Round | 18-Jun-2019 | Completed | Generating Revenue | |||
2. Accelerator/Incubator | 11-Jun-2018 | Completed | Generating Revenue | |||
1. Grant | 09-May-2018 | Completed | Generating Revenue |
Instalimb Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
CC Class Preferred | ||||||||
C Preferred | ||||||||
B Preferred | 4,673 | $356.96 | $356.96 | 1x | $356.96 | 16.86% | ||
A Preferred | 4,200 | $133.43 | $133.43 | 1x | $133.43 | 15.15% |
Instalimb Patents
Instalimb Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-WO2019245043-A1 | Prosthetic limb socket | Active | 22-Jun-2018 | ||
JP-7423069-B2 | Prosthetic socket | Active | 22-Jun-2018 | ||
JP-7264524-B2 | Prosthetic limb shape data generation system, method, program and prosthetic limb generation system | Active | 21-Nov-2017 | ||
JP-WO2019103010-A1 | Artificial limb shape data generation system | Active | 21-Nov-2017 | ||
US-20200356073-A1 | Prosthesis shape data generation system | Pending | 21-Nov-2017 | A61F2/80 |
Instalimb Signals
Instalimb Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Dai-Ichi Life Insurance | Holding Company | Minority | ||
IT-Farm | Venture Capital | Minority | ||
JIC Venture Growth Investments | Venture Capital | Minority | ||
Leave a Nest Capital | Venture Capital | Minority | ||
Nippon Express | Corporation | Minority |
Instalimb FAQs
-
When was Instalimb founded?
Instalimb was founded in 2017.
-
Where is Instalimb headquartered?
Instalimb is headquartered in Tokyo, Japan.
-
What is the size of Instalimb?
Instalimb has 49 total employees.
-
What industry is Instalimb in?
Instalimb’s primary industry is Therapeutic Devices.
-
Is Instalimb a private or public company?
Instalimb is a Private company.
-
What is the current valuation of Instalimb?
The current valuation of Instalimb is
. -
What is Instalimb’s current revenue?
The current revenue for Instalimb is
. -
How much funding has Instalimb raised over time?
Instalimb has raised $10.1M.
-
Who are Instalimb’s investors?
Dai-Ichi Life Insurance, IT-Farm, JIC Venture Growth Investments, Leave a Nest Capital, and Nippon Express are 5 of 14 investors who have invested in Instalimb.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »